Skip to content

Clinical trials

Completed Leukemia, Myeloid, Acute trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Myeloid, Acute Status: Completed Country / region: South Korea Clear all

54 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20031
20041
20072
20081
20094
20102
20114
20138
20143
20154
20164
20178
20183
20203
20212
20221
20231
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed54

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Asan Medical Center8
Novartis Pharmaceuticals6
Astellas Pharma Global Development, Inc.4
AbbVie3
Celgene3
Astex Pharmaceuticals, Inc.2
Daiichi Sankyo2
Janssen Research & Development, LLC2
Seoul National University Hospital2
Accenture1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Myeloid, Acute54
Myelodysplastic Syndromes14
Leukemia12
Leukemia, Myelomonocytic, Chronic10
Precursor Cell Lymphoblastic Leukemia-Lymphoma7
Multiple Myeloma6
Neoplasms6
Blast Crisis5
Congenital Abnormalities5
Leukemia, Lymphocytic, Chronic, B-Cell5

Trials

Showing 1 to 25 of 54. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.